Skip to content

Stimulation of the anterior thalamic nucleus in refractory epilepsy: Neurophysiological aspects and effects on cognition

Stimulation of the anterior thalamic nucleus in refractory epilepsy: Neurophysiological aspects and effects on cognition - Effects of DBS in epilepsy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44832
Enrollment
28
Registered
2014-06-02
Start date
2015-07-07
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Seizure disorder

Interventions

None listed

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Medically refractory epilepsy No possibility for resective epilepsy surgery Incapacitating epilepsy or seizures (no absolute minimal frequency) Minimum age 18 years

Exclusion criteria

Exclusion criteria: Underlying malignancies, whenever life expectancy is lower than 2 years Co-medication with anti-inflammatory drugs or systemic diseases with inflammation are possible exclusion criteria, depending on severity and stability. Whenever there is a stable disease, with a reasonable chance of sustained stability, and stable medication, inclusion is possible. In other cases, patients will be excluded. There also may be clinical grounds on which the specialist team may decide that a patient does or does not qualify for ATN-DBS treatment. The team will be more hesitant in case of (co-existent) psychogenic, non-epileptic attacks, or low IQ (below 70).

Design outcomes

Primary

MeasureTime frame
This observational study aims at the registration of ATN signals in the immediate postoperative stage. We compare these parameters in groups with good response and patients with poor response. Note that these parameters are (up till now) not clinically significant end points.

Secondary

MeasureTime frame
-

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)